Discounted Cash Flow
Teva Pharmaceutical Industries Ltd. ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $21.9b | $68.0m | $4.3b | 0.3% | $0.07 |
| 2017 | $22.4b (2.2%) | $-16.3b (-24019.1%) | $1.4b (-68.8%) | -72.7% (-23504.1%) | $-16.26 (-23328.6%) |
| 2018 | $18.9b (-15.8%) | $-2.1b (86.8%) | $1.8b (32.9%) | -11.4% (84.3%) | $-2.35 (85.5%) |
| 2019 | $16.9b (-10.4%) | $-999.0m (53.5%) | $223.0m (-87.6%) | -5.9% (48.1%) | $-0.91 (61.3%) |
| 2020 | $16.7b (-1.4%) | $-4.0b (-299.4%) | $638.0m (186.1%) | -24.0% (-304.9%) | $-3.64 (-300.0%) |
| 2021 | $15.9b (-4.7%) | $417.0m (110.5%) | $236.0m (-63.0%) | 2.6% (111.0%) | $0.38 (110.4%) |
| 2022 | $14.9b (-6.0%) | $-2.4b (-664.3%) | $1.0b (341.5%) | -15.8% (-700.3%) | $-2.12 (-657.9%) |
| 2023 | $15.8b (6.2%) | $-559.0m (76.2%) | $842.0m (-19.2%) | -3.5% (77.6%) | $-0.50 (76.4%) |
| 2024 | $16.5b (4.4%) | $-1.6b (-193.2%) | $749.0m (-11.0%) | -9.9% (-180.8%) | $-1.45 (-190.0%) |
| 2025 | $17.3b (4.3%) | $1.4b (186.0%) | $1.1b (53.3%) | 8.2% (182.5%) | $1.23 (184.8%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.